ADENOKARSINOMA KOLON PDF

admin

Profil Adenokarsinoma Kolon di RSUP Prof Dr. R. D. Kandou dan Siloam Hospitals Periode Januari – Juni Pemberian Kombinasi 5FU-Leucovorin dengan Phaleria macrocarpa terhadap Proliferasi Sel dan Diameter Adenokarsinoma Kolon Tikus Sprague dawley. PROPOLIS TERHADAP KSPRESI PROTEIN CASPASE 8, APOPTOSIS, DAN PROLIFERASI PADA KULTUR SEL ADENOKARSINOMA KOLON (WiDr).

Author: Taugore Kim
Country: Martinique
Language: English (Spanish)
Genre: Relationship
Published (Last): 20 March 2014
Pages: 325
PDF File Size: 15.83 Mb
ePub File Size: 6.49 Mb
ISBN: 492-1-15502-642-4
Downloads: 94835
Price: Free* [*Free Regsitration Required]
Uploader: Bramuro

Inhibiting new blood vessel formation denies blood, oxygen, and other nutrients needed for tumor growth. Yytrium was injected intra-arterially into the hepatic artery.

Protective Effect of Caffeic Acid Phenethyl. Log In Sign Up.

Bevacizumab is indicated in combination with a fluoropyrimidine-based chemotherapy as a first-line or second-line treatment for metastatic colorectal cancer. Though information on results of adjuvant therapy in stage II and III colon cancer is limited, a data set assembled by the Adjuvant Colon Cancer Endpoints group with fluorouracil-based adjuvant therapy was recently analyzed.

Jurnal Kedokteran Brawijaya, Vol 29, No. The authors concluded that adjuvant adenokarsionma provides significant disease-free survival benefit because it reduces the recurrence rate particularly within the first 2 years of adjuvant therapy but with some benefit in years Iranian Jour of Pharm Research; 10 2: Natural Product Communications, 5 1: Propolis diketahui memiliki aktivitas anti kanker.

Bcl-2 family proteins adenojarsinoma the release of apoptogenic cytochrome C by the mitochondrial channel VDAC. Conclusion P macrocarpa has the potential as immunostimulatory which can increase the effectiveness of 5FU-leucovorin chemotherapy in terms lowering the cell proliferation and decrease the diameter of adenocarsinoma colon of Sprague dawley rat.

Capecitabine itself is inactive.

They also examined the influence of the KRAS mutation status. Indicated to treat colorectal cancer that has metastasized following standard chemotherapy. Proliferasi sel dinilai dengan pengecatan IHC Ki sedangkan diameter massa tumor diukur menggunakan caliper tumor. Sebagian besar pasien kanker kolorektal didiagnosis dalam stadium yang sudah tidak dapat dioperasi. Targeting mTOR network in colorectal cancer therapy. Bevacizumab Avastin Murine derived monoclonal antibody that inhibits angiogenesis by targeting and inhibiting vascular endothelial growth factor VEGF.

  EPWA CHARTS PDF

TERAPI ADENOKARSINOMA KOLON | LIA AMELIA –

Regorafenib Stivargaa kinase inhibitor, was approved in September This study used a female Sprague dawley white rats were divided into 4 groups: Journal of Venomous Animals and Toxin, 6 2: Binds to and stabilizes ternary complex of FdUTP intracellular active metabolite of fluoropyrimidines and thymidylate synthetase TSaugmenting cytotoxic adeonkarsinoma of adennokarsinoma.

Pengamatan ekspresi protein Caspase 8 dilakukan dengan metode imunositokimia, pengamatan apoptosis dilakukan dengan double staining menggunakan adenokarsijoma akridin oranye—etidium bromide, sedangkan pengamatan proliferasi menggunakan MTT assay dengan doubling time. It is indicated for patients with metastatic colorectal cancer mCRC who have been previously treated with fluoropyrimidine- oxaliplatin- and irinotecan-based chemotherapy; an anti—vascular endothelial growth factor VEGF therapy eg, bevacizumab, ziv-aflibercept ; and, if KRAS wild type, an anti—epidermal growth factor receptor EGFR therapy eg, cetuximab, panitumumab [64].

Complementary and Alternative Qdenokarsinoma in the United States. Bokemeyer et al examined the overall response rate when combining cetuximab with oxaliplatin, leucovorin, and fluorouracil FOLFOX-4as opposed to the regimen without cetuximab, for first-line treatment of metastatic colorectal cancer in a randomized study.

Journal Medicine Food, 14 6: Undergoes hydrolysis in liver and tissues to form the active moiety fluorouracilinhibiting thymidylate synthetase, which in turn blocks methylation of deoxyuridylic acid to th Leucovorin Folinic acid, Citrovorum Factor Reduced form of folic acid that does not require enzymatic reduction reaction for activation.

Cell proliferation was assessed by IHC Ki staining, while the diameter of the tumor mass was adenokarsinomx using a caliper tumor.

Mekanisme anti kanker propolis melalui induksi apoptosis dan juga melalui penghambatan proliferasi dalam siklus sel. A study by Seymour et al found that with appropriate designs, including reduced starting doses of chemotherapy, frail and elderly patients can participate in randomized controlled trials, which is important because they are often under-represented in such trials despite being frequently treated with chemotherapy.

Asian Pacific Journal Cancer Preventions, 7; p. Penelitian ini merupakan penelitian experimental laboratories, post test with control group design.

  HADEES QUDSI IN URDU PDF

Jurnal e-CliniC (eCl)

Covalently binds to DNA with preferential binding to the N-7 position of guanine and adenine. Current standard therapy for colon cancer involves combination chemotherapy.

Insidensi kanker kolon di seluruh dunia masih tinggi dan menjadi penyebab kematian terbanyak kategori penyakit tidak menular. No adennokarsinoma comparisons between panitumumab containing combinations versus cetuximab or even bevacizumab anti-VEGFR monoclonal antibody chemotherapy combinations in patients with wild-type KRAS tumors have been reported, leaving it up to the oncologist to prioritize the choice or sequence of monoclonals in this patient population.

Kolob on Human Cancer Cell Lines. Adjuvant Chemotherapy for Colorectal Cancer. Regorafenib Stivarga Regorafenib is a tyrosine kinase inhibitor.

User Username Password Remember me.

Perpustakaan Unika Atma Jaya

Method Laboratory experimental adenokardinoma with post-test only design. The study concluded that adding bevacizumab to fluorouracil-based chemotherapy improved overall survival and progression- free survival in older patients as it does in younger patients, without increased risks of treatment in the older age group.

They concluded that the overall response rate for cetuximab plus FOLFOX-4 was higher than with FOLFOX-4 alone though a statistically significant increase in odds for a response with the addition of cetuximab could not be established, except in adenokarsinima with KRAS wild-type tumors, for whom the addition of cetuximab increased chance of response and lowered risk of disease progression.

Has activity as single agent that inhibits DNA replication and transcription. Penelitian dilakukan dengan desain eksperimental laboratorik kooon desain post test only menggunakan tikus putih betina strain Sprague dawley dibagi menjadi 4 kelompok yaitu kelompok K kontrolP1 kelompok kemoterapiP2 kelompok P.

Introduction The incidence of colon cancer in the world is still high and the most cause of death of non-communicable disease category.

Subscribe US Now